Greg Lohman

Greg Lohman is a Senior Scientist at New England Biolabs, leading a research group focused on the biochemistry of DNA enzymes, particularly DNA ligases, exonucleases, and structure-dependent endonucleases, with an emphasis on high-risk applications and product development. Prior to this role, Greg Lohman held positions as a Staff Scientist and Research Scientist in the DNA Enzymes Division, concentrating on the discovery of new polynucleotide ligase activities. Greg's earlier experience includes a postdoctoral researcher role at New England Biolabs, an MCAT General Chemistry Instructor at The Princeton Review, a Research Scientist at Ancora Pharmaceuticals developing carbohydrate-based vaccine candidates, and a contractor at Momenta Pharmaceuticals studying peptide drug preparation. Greg Lohman earned a Ph.D. in Chemistry from the Massachusetts Institute of Technology and a B.S./B.S. in Chemistry and Biology from Case Western Reserve University.